CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference

Audio By Carbonatix

BRISBANE, Calif.--(BUSINESS WIRE)--Feb 18, 2026--

CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced the company will participate in the Raymond James 47 th Annual Institutional Investors Conference in Orlando, FL on Tuesday, March 3, 2026.

About CareDx

CareDx is a precision medicine company dedicated to improving outcomes for transplant patients and advancing organ health. The Company’s integrated solutions include non‑invasive molecular testing for heart, kidney, and lung transplants; laboratory products; digital health technologies; and patient solutions that support care before and after transplant. CareDx is the leading provider of genomics‑based information for transplant patients. For more information, please visit www.caredx.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260218713403/en/

CONTACT: Investor Relations

Caroline Corner

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA FLORIDA

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES SURGERY RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: CareDx, Inc.

Copyright Business Wire 2026.

PUB: 02/18/2026 08:00 AM/DISC: 02/18/2026 08:03 AM

http://www.businesswire.com/news/home/20260218713403/en